Cross-talk between IFN-γ and TWEAK through miR-149 amplifies skin inflammation in psoriasis.

[1]  J. Gudjonsson,et al.  The influence of interferon on healthy and diseased skin. , 2020, Cytokine.

[2]  T. Nomura,et al.  Cutaneous p38 mitogen-activated protein kinase activation triggers psoriatic dermatitis. , 2019, The Journal of allergy and clinical immunology.

[3]  L. Pasquali,et al.  Next generation sequencing identifies the keratinocyte-specific miRNA signature of psoriasis. , 2019, The Journal of investigative dermatology.

[4]  L. Pasquali,et al.  The Keratinocyte Transcriptome in Psoriasis: Pathways Related to Immune Responses, Cell Cycle and Keratinization. , 2019, Acta dermato-venereologica.

[5]  Jing Liu,et al.  TWEAK/Fn14 Signals Mediate Burn Wound Repair. , 2019, The Journal of investigative dermatology.

[6]  E. Halilovic,et al.  Serum Concentrations of Interferon Gamma (IFN-γ) in Patients with Psoriasis: Correlation with Clinical Type and Severity of the Disease , 2018, Medical archives.

[7]  Alex Bateman,et al.  RNAcentral: a hub of information for non-coding RNA sequences , 2018, Nucleic Acids Res..

[8]  A. Pivarcsi,et al.  Tofacitinib Represses the Janus Kinase-Signal Transducer and Activators of Transcription Signalling Pathway in Keratinocytes. , 2018, Acta dermato-venereologica.

[9]  Jing Wu,et al.  Fn14 deficiency ameliorates psoriasis-like skin disease in a murine model , 2018, Cell Death & Disease.

[10]  Liang Chen,et al.  MiR-149 suppresses the inflammatory response of chondrocytes in osteoarthritis by down-regulating the activation of TAK1/NF-κB. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[11]  L. Iversen,et al.  Old and New Biological Therapies for Psoriasis , 2017, International journal of molecular sciences.

[12]  James T. Elder,et al.  IFN-γ and TNF-α synergism may provide a link between psoriasis and inflammatory atherogenesis , 2017, Scientific Reports.

[13]  James T. Elder,et al.  miR-146b Probably Assists miRNA-146a in the Suppression of Keratinocyte Proliferation and Inflammatory Responses in Psoriasis. , 2017, The Journal of investigative dermatology.

[14]  Zhe Wang,et al.  MicroRNA-149 contributes to scarless wound healing by attenuating inflammatory response. , 2017, Molecular medicine reports.

[15]  M. Croft,et al.  TWEAK mediates inflammation in experimental atopic dermatitis and psoriasis , 2017, Nature Communications.

[16]  P. Nikamo,et al.  MicroRNA‐146a suppresses IL‐17–mediated skin inflammation and is genetically associated with psoriasis , 2017, The Journal of allergy and clinical immunology.

[17]  L. French,et al.  IFN-γ Primes Keratinocytes for HSV-1-Induced Inflammasome Activation. , 2016, The Journal of investigative dermatology.

[18]  Meifeng Xu,et al.  TWEAK/Fn14 activation induces keratinocyte proliferation under psoriatic inflammation , 2016, Experimental dermatology.

[19]  Ying Yu,et al.  Epigenetic silencing of microRNA-149 in cancer-associated fibroblasts mediates prostaglandin E2/interleukin-6 signaling in the tumor microenvironment , 2015, Cell Research.

[20]  C. Putterman,et al.  TWEAK/Fn14 Signaling Involvement in the Pathogenesis of Cutaneous Disease in the MRL/lpr Model of Spontaneous Lupus , 2015, The Journal of investigative dermatology.

[21]  Guangxian Xu,et al.  MicroRNA‐149 Negatively Regulates TLR‐Triggered Inflammatory Response in Macrophages by Targeting MyD88 , 2014, Journal of cellular biochemistry.

[22]  Mayte Suárez-Fariñas,et al.  Immunology of psoriasis. , 2014, Annual review of immunology.

[23]  Andrew Johnston,et al.  Transcriptome analysis of psoriasis in a large case-control sample: RNA-seq provides insights into disease mechanisms , 2014, The Journal of investigative dermatology.

[24]  James T. Elder,et al.  Modulation of Epidermal Transcription Circuits in Psoriasis: New Links between Inflammation and Hyperproliferation , 2013, PloS one.

[25]  Eugenia G. Giannopoulou,et al.  Synergistic activation of inflammatory cytokine genes by interferon-γ-induced chromatin remodeling and toll-like receptor signaling. , 2013, Immunity.

[26]  Andrew Johnston,et al.  Dissecting the psoriasis transcriptome: inflammatory- and cytokine-driven gene expression in lesions from 163 patients , 2013, BMC Genomics.

[27]  A. Pivarcsi,et al.  MicroRNA-31 Is Overexpressed in Psoriasis and Modulates Inflammatory Cytokine and Chemokine Production in Keratinocytes via Targeting Serine/Threonine Kinase 40 , 2013, The Journal of Immunology.

[28]  S. Kauppinen,et al.  MiR‐21 is up‐regulated in psoriasis and suppresses T cell apoptosis , 2012, Experimental dermatology.

[29]  M. Suárez-Fariñas,et al.  A single intradermal injection of IFN-γ induces an inflammatory state in both non-lesional psoriatic and healthy skin , 2011, The Journal of investigative dermatology.

[30]  T. Zheng,et al.  TWEAK/Fn14 pathway: an immunological switch for shaping tissue responses , 2011, Immunological reviews.

[31]  L. Kemény,et al.  MiR-125b, a microRNA downregulated in psoriasis, modulates keratinocyte proliferation by targeting FGFR2. , 2011, The Journal of investigative dermatology.

[32]  Iris Barshack,et al.  MiRNA Expression in Psoriatic Skin: Reciprocal Regulation of hsa-miR-99a and IGF-1R , 2011, PloS one.

[33]  C. Johansen,et al.  Preferential inhibition of the mRNA expression of p38 mitogen‐activated protein kinase regulated cytokines in psoriatic skin by anti‐TNFα therapy , 2010, The British journal of dermatology.

[34]  A. Pivarcsi,et al.  microRNAs in Inflammation , 2009, International reviews of immunology.

[35]  M. Abdallah,et al.  Serum interferon-gamma is a psoriasis severity and prognostic marker. , 2009, Cutis.

[36]  Frank O. Nestle,et al.  Mechanisms of Disease: Psoriasis. , 2009 .

[37]  D. Bartel.  MicroRNAs: Target Recognition and Regulatory Functions , 2009, Cell.

[38]  Lisa C. Zaba,et al.  Th17 cytokines interleukin (IL)‐17 and IL‐22 modulate distinct inflammatory and keratinocyte‐response pathways , 2008, The British journal of dermatology.

[39]  P. Janson,et al.  MicroRNAs: Novel Regulators Involved in the Pathogenesis of Psoriasis? , 2007, PloS one.

[40]  J. Woodgett,et al.  IFN-gamma suppresses IL-10 production and synergizes with TLR2 by regulating GSK3 and CREB/AP-1 proteins. , 2006, Immunity.

[41]  K. Kristiansen,et al.  The mitogen‐activated protein kinases p38 and ERK1/2 are increased in lesional psoriatic skin , 2005, The British journal of dermatology.

[42]  K. Gardner,et al.  Identification of small-molecule antagonists that inhibit an activator: coactivator interaction. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[43]  Mark Lebwohl,et al.  Psoriasis , 1906, The Lancet.

[44]  Hiroyuki Suzuki,et al.  Protein kinase C-dependent upregulation of miR-203 induces the differentiation of human keratinocytes. , 2010, The Journal of investigative dermatology.